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Both leucocyte and erythrocyte counts of blood sharply decreased in Swiss mice after 2 
weeks of intraperitoneal treatment with potassium dichromate (4 mg/Kg for 5 days per week). 
A marked neutropenia along with a relative rise in lymphocyte count were also noted. 
Chromosomal abnormalities (chromatid break, ring chromosome formation and aneuploidy) 
and micronucleus formation were observed in both lymphopoietic and myelopoietic tissues 
(spleen and bone marrow, respectively). The overall findings indicate that a cytotoxic potential 
of hexavalent chromium may result in myelosuppression, lymphopenia as well as suppression 
of erythropoiesis. However, a higher incidence of chromosomal abnormalities and 
micronucleated cells in the bone marrow than in the spleen suggests hexavalent chromium to 
be relatively more myelosuppressive than lymphopenic in action.  
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Introduction 
The heavy metal chromium in the form of its hexavalent 
salts has long been marked as an environmental pollutant by 
toxicologists as well as physiologists. Hexavalent chromium 
has been identified as a potent inorganic carcinogen [1, 2]. It 
has also been known to exert considerable hepatotoxic and 
nephrotoxic actions in animal models [3, 4]. Besides, 
hexavalent chromium has been reported to adversely affect the 
reproductive function in both sexes of laboratory mouse [5]. 
Hexavalent chromium has also been known to possess 
marked clastogenic (chromosome damaging) as well as 
cytotoxic potentials. Hexavalent chromium salts (potassium 
dichromate and potassium chromate) were found to produce 
chromosomal aberrations in           (i) human leucocytes grown 
in vitro [6], (ii) phytohaemagglutinin-stimulated human 
lymphocytes reared in vitro [7] and (iii) Chinese hamster 
ovarian cells cultured in vitro [8]. Chromosomal aberrations 
were also reported in the bone marrow of mice treated with 
hexavalent chromium along with drinking water [9]. Hexavalent 
chromium at concentrations above 2.5 µM has been found to 
affect the viability of mouse peritoneal macrophages in vitro in 
a concentration-dependent manner [10]. Recently, it has been 
reported that hexavalent chromium, at concentrations above 1 
µM, reduces the viability of human macrophages               in 
vitro [11]. Another recent report indicates that potassium 
dichromate, when added in soil (250 mg/Kg), may exert a 
cytotoxic action in germinating seeds and growing seedlings of 
plants [12]. 
In view of the aforementioned reports on clastogenic and 
cytotoxic potentials of hexavalent chromium, the present 
authors have been interested to make a preliminary 
investigation on whether chromium is likely to suppress in vivo 
the production of cells concerned with immunity, in a murine 
model, or not. Lymphocytes of vertebrate body are concerned 
with elaboration of humoral immune response while neutrophils 
are concerned with innate immunity involving phagocytosis 
[13]. The spleen is a major lymphopoietic organ while the bone 
marrow is the site for myelopoiesis (production of 
granulocytes) in mammalian body [14]. In the present study, 
the probable immunosuppressive (myelosuppressive and 
lymphopenic) potential of hexavalent chromium has been 
evaluated through examination of (i) total count of leucocytes 
of blood, (ii) differential counts of all kinds of leucocytes of 
blood, (iii) chromosomal abnormalities in lymphopoietic and 
myelopoietic tissues (spleen and bone marrow, respectively) 
and (iv) micronucleus formation in lymphopoietic and 
myelopoietic tissues in a murine model. Simultaneously, 
erythrocyte count of blood has also been recorded to assess 
whether chromium also suppresses erythropoiesis in the bone 
marrow, or not.  
The rationale behind undertaking the present study is that 
hexavalent chromium appears to be a major environmental 
pollutant in the tannery-belt of the Greater Kolkata. An 
indiscriminate discharge of a huge quantity of a chromium-rich 
effluent by several tanneries in the Bantala Leather Complex, 
where the construction of suitable chromium-treatment plants 
is still pending, is likely to adversely affect the health of the 
tannery workers as well as the people living around the 
tanneries [15]. It is, therefore, necessary to obtain as much 
information as possible on the adverse physiological effects of 
chromium.  
Materials and Methods  
Adult (8 weeks old), inbred and healthy, male, albino mice 
of the Swiss strain were divided into control and experimental 
groups. Only male mice were taken in analogy with the fact 
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that the tannery workers of our state are generally males. The 
mice were housed in a few polypropylene cages with saw-dust 
for bedding, in a well-ventilated and well-lit animal room of the 
Department of Zoology, Presidency University, Kolkata. The 
mice were provided with food pellets and filtered tap-water ad 
libitum. Animal care was taken as properly as possible under 
the regular supervision of an Institutional Animal Ethical 
Committee whose registration number with the Committee for 
the Purpose of Control and Supervision on Experiments on 
Animals, Ministry of Environment and Forests, Government of 
India, is 796/03/ac/CPCSEA.  
The experimental mice were intraperitoneally injected with 
an aqueous solution of potassium dichromate (K2Cr2O7) at a 
dose of 4 mg/Kg body weight for 5 consecutive days per week, 
for a total period of 2 weeks. The selected dose of K2Cr2O7 
was nearly one-tenth of its LD50 value (39 mg/Kg) for mice [4]. 
The control mice were injected with physiological saline (0.9%) 
for a similar tenure.  
After 1 and 2 weeks of chromium treatement, 6 
experimental and 6 control mice were anaesthetised under 
ether vapour and blood samples were collected inside 
heparinised vials by cardiac puncture. Total counts (TC) of 
erythrocytes and leucocytes were determined by refined visual 
methods using a haemocytometer having an improved 
Neubauer counting chamber [16]. Differential counts (DC) of 
leucocytes were determined from microscopic examination of 
blood smears stained with 10% Giemsa’s stain buffered to pH 
7.0 with 0.1 M phosphate buffer [16]. 
Chromosomal preparations were made from both 
lymphopoietic and myelopoietic tissues (spleen and bone 
marrow, respectively) of both experimental and control groups 
of mice by using the conventional flame-drying technique [17]. 
Micronucleus test was carried out on both spleen and bone 
marrow cells of the animals following the popular citrate-
Giemsa method [18]. 
Results and Discussion  
At the end of the first week of K2Cr2O7 treatment, TC of 
erythrocytes was considerably decreased in the experimental 
mice, as compared to that in the controls (p < 0.001). However, 
at this stage, both TC and DC of leucocytes did not show any 
significant difference between the control and the experimental 
groups of mice (p > 0.05 in either case). At the end of the 
second week of treatment, TC of erythrocytes was found to be 
further decreased. Moreover, TC of leucocytes was noted to be 
markedly reduced in the experimental mice, as compared to 
that in the controls (p < 0.001). Interestingly, DC of leucocytes 
revealed that the count of lymphocytes was considerably 
higher in the experimental mice than in their control 
counterparts (p < 0.001) while the count of neutrophils was 
significantly lower in the former than in the latter (p < 0.001). 
The counts of blood cells in the experimental and the control 
mice, as recorded during the present study, have been 
summarized in Table 1.  
Chromosomal abnormalities were occasionally observed 
in both spleen and bone marrow of the experimental mice. A 
metaphase plate of a control mouse showed 40 telocentric 
chromosomes, each with two chromatids of equal length. On 
the other hand, one or more chromatid breaks, formation of 
one or more ring chromosomes and aneuploidy (loss of one or 
more chromosomes) were occasionally observed in the 
metaphase plates of the experimental mice (Fig. 1 and Fig. 2). 
Chromosomal abnormalities were more frequently encountered 
in the bone marrow than in the spleen, at the end of either 1 or 
2 weeks of K2Cr2O7 treatment. Moreover, as summarized in 
Table 2, the overall percentage of chromosomal abnormalities 
was found to be higher in both the tissues, after 2 weeks than 
after 1 week of K2Cr2O7 treatment. 
Micronuclei were seldom observed in either the spleen 
cells or the bone marrow cells of any control mouse. On the 
other hand, a progressive increase in the incidence of 
micronuclei in both spleen cells and bone marrow cells was 
noted in the experimental mice after 1 and 2 weeks of K2Cr2O7 
treatment (Table 3). A micronucleus appeared as a small and 
rounded body (1-2 µm in diameter) lying in the cell cytoplasm 
and staining violet as intensely as the main nucleus of a cell 
(Fig. 3 and Fig. 4). The percentage of micronucleus-bearing 
cells was found to be higher in the bone marrow than in the 
spleen after 1 as well as 2 weeks of K2Cr2O7 treatment.  
The finding of a progressive decrease in TC of 
erythrocytes in the K2Cr2O7-treated mice very strongly 
indicates a suppressive action of hexavalent chromium on 
erythropoiesis. Moreover, a marked reduction in TC of 
leucocytes after 2 weeks of tretment indicates that hexavalent 
chromium also exerts a suppressive action on leucopoiesis in 
the murine model. However, the suppressive action on 
leucopoiesis is initiated somewhat later than that on 
erythropoiesis. 
After 2 weeks of K2Cr2O7 treatment, TC of both leucocytes 
and erythrocytes are found to be sharply decreased along with 
a marked fall in DC of the neutrophils (which causes and 
apparent and relative rise in DC of the lymphocytes). The 
findings distinctly indicate that hexavalent chromium exerts a 
relatively stronger suppressive action on erythropoiesis and 
myelopoiesis in the bone marrow than on lymphopoiesis in the 
spleen of the murine model. 
The finding of various kinds of chromosomal 
abnormalities in both spleen and bone marrow of the 
experimental mice is indicative of a strong cytotoxic potential of 
chromium. An occasional formation of micronucleus also 
provides a similar indication; a micronucleus has long been 
known to originate due to condensation of broken 
chromosomal parts dislodged to the cytoplasm from the nuclei 
of the cells [19]. The cytotoxic potential of hexavalent 
chromium may be responsible for considerable suppression of 
lymphopoiesis in the spleen and both erythropoiesis and 
myelopoiesis in the bone marrow in the murine model under 
study.
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Table 1. Blood cell counts (mean ± s. d.)  in K2Cr2O7 -treated and control Swiss mice (6 mice per group). 
Blood cells 
Groups of mice Groups of mice 
1 week after treatment Respective controls 2 weeks after 
treatment 
Respective controls 
Erythrocyte 
(million/c.mm) 5.01 ± 0.33* 5.64 ± 0.27 4.76 ± 0.23* 5.66 ± 0.35 
Leucocyte 
(thousand/c.mm) 6.47 ± 0.43 6.55 ± 0.51 4.91 ± 0.28* 6.43 ± 0.34 
Lymphocyte (%) 75.50 ± 2.99 76.83 ± 2.11 84.33 ± 2.87* 75.83 ± 2.41 
Neutrophil (%) 19.67 ± 2.87 17.67 ± 2.43 10.67 ± 3.14* 19.00 ± 3.26 
Monocyte (%) 3.50 ± 0.50 3.67 ± 0.74 3.67 ± 0.74 3.67 ± 0.74 
Eosinophil (%) 1.33 ± 0.47 1.83 ± 0.69 1.33 ± 0.47 1.50 ± 0.50 
*Significantly different from respective controls (p < 0.001). 
 
Table 2. Chromosomal abnormalities (% of 50 metaphase plates examined per group) in K2Cr2O7 -treated and control Swiss mice  
Tissue and chromosomal 
abnormality 
Groups of mice Groups of mice 
1 week after 
treatment 
Respective controls 2 weeks after 
treatment 
Respective controls 
(A) Spleen : 
(i) chromatid break 
(ii) ring chromosome 
(iii) aneuploidy 
 
12 
4 
4 
 
0 
0 
0 
 
16 
4 
4 
 
0 
0 
0 
(B) Bone marrow : 
(i) chromatid break 
(ii) ring chromosome 
(iii) aneuploidy 
 
18 
4 
4 
 
0 
0 
0 
 
22 
6 
6 
 
0 
0 
0 
 
Table 3. Micronuclei formation (% of 200 cells examined per group) in K2Cr2O7 -treated and control Swiss mice  
Tissue 
Groups of mice Groups of mice 
1 week after 
treatment 
Respective controls 2 weeks after 
treatment 
Respective controls 
Spleen  2.0 0 3.5 0.5 
Bone marrow  3.5 0.5 5.5 0.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. A metaphase plate from spleen of a mouse (after 2 weeks of 
K2Cr2O7 treatment), showing aneuploidy (chromosome number = 39) 
and chromatid breaks (b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. A metaphase plate from bone marrow of a mouse (after 2 
weeks of K2Cr2O7 treatment), showing aneuploidy (chromosome 
number = 39), chromatid break (b) and ring chromosome (r). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Micronucleus (m) formation in a spleen cell of a mouse (after 2 
weeks of K2Cr2O7 treatment). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Micronucleus (m) formation in a bone marrow cell of a mouse 
(after 2 weeks of K2Cr2O7 treatment). 
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Conclusion 
It may be concluded from the present study that 
hexavalent chromium exerts a marked cytotoxic action on 
lymphopoietic as well as myelopoietic tissues (spleen and 
bone marrow, respectively) of a murine model, resulting in 
marked leucopenia (along with a markedly decreased 
erythrocyte count). The leucopenic effect is, on the other hand, 
indicative of a probable immunosuppressive effect of 
chromium. However, a higher incidence of chromosomal 
abnormalities and micronucleated cells in the bone marrow 
than in the spleen indicates that hexavalent chromium is 
relatively more myelosuppressive than lymphopenic  in action. 
Finally, an extrapolation of the findings of the present 
study in a murine model hints to the necessity of periodic 
monitoring of blood cell counts in the tannery workers of our 
state, who are continually getting exposed to hexavalent 
chromium on account of their occupation. 
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